XML 73 R62.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders Equity (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Aug. 05, 2020
Shares reserved for grants 118,329      
Stock based compensation for stock options $ 53,000 $ 0    
Net of estimated forfeitures of approximately 12.00%      
Stock based compensation for grants totataling $ 213,000 $ 217,000    
Weighted average estimated fair value $ 1.24      
Weighted-average vesting period 2 years 9 months 7 days      
Estimated fair value of unamortized compensation 303,750      
Exercise price $ 1.00      
Closing price of common stock $ 4.45      
Purchase of aggregate common stock outstanding 969,525      
warrants issued to purchase common stock 969,525      
Stock option awards $ 270,000      
Common stock shares authorized 993,200      
Common stock shares authorized 20,000,000   20,000,000  
10 May 2023 [Member]        
Common stock shares authorized 1,900,000      
Held-to-Maturity Securities US Treasury Securities [Member]        
Common stock shares authorized 700,000     1,400,000